miR-217-5p Regulates Microglia-Related Neuroinflammation via NF1 and Further Modulates Chronic Constriction...

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neuropathic pain (NP) significantly impacts quality of life due to high incidence and limited treatments.
• Identifying novel therapeutic targets is crucial for effective NP management.

Purpose of the Study:

• To investigate the role and mechanisms of microRNA-217-5p (miR-217-5p) in neuropathic pain.
• To explore miR-217-5p as a potential therapeutic target for NP.

Main Methods:

• Evaluated miR-217-5p expression and function in rat models of neuropathic pain (CCI) and lipopolysaccharide (LPS)-induced microglia.
• Assessed pain behaviors, M1 polarization, cell viability, inflammation, and oxidative stress.
• Identified NF1 as a direct target of miR-217-5p.

Main Results:

• miR-217-5p was significantly downregulated in both CCI rats and LPS-treated microglia.
• Overexpression of miR-217-5p reduced pain, inflammation, and oxidative stress in rats and microglia.
• miR-217-5p suppressed M1 polarization and improved cell viability in microglia.
• NF1 was negatively regulated by miR-217-5p, and its overexpression reversed miR-217-5p's protective effects.

Conclusions:

• miR-217-5p plays a protective role in neuropathic pain by modulating microglia-related neuroinflammation.
• Targeting NF1, miR-217-5p represents a potential therapeutic strategy for neuropathic pain.